
J&J Secures 9.5% Stake in Kenvue through Share Exchange Offer
Johnson & Johnson expects to retain a 9.5% stake in its newly separated consumer health unit, Kenvue, after completing a share exchange offer. The company launched the exchange offer last month, allowing its stockholders to opt for shares of the former consumer health unit related to the spinoff. Shares of Kenvue rose 1.4% in premarket trading.